Soiken Holdings Inc.
Notice regarding the differences between the consolidated full-year earnings forecast for the year ending June 2026 and actual results
Full-year consolidated earnings forecast for the year ending June 2026 was raised. Revenue from 3,860 million yen to 3,871 million yen; operating income from -180 million yen to 275 million yen; and other segment adjustments. Profitability improvements are progressing in Healthcare Support and Dietary Supplements.
Key Figures
- Revenue: 3,871 百万円
- Operating income: 275 百万円
- Ordinary income: 287 百万円
AI要約
Section heading
This report discloses revised details on the difference between the full-year consolidated earnings forecast for the year ending June 2026 and actual results. Through progress in structural reforms from the third quarter onward and the effects of profitability-improvement measures, the earnings outlook has been raised. By segment, improved profitability in Healthcare Support and Dietary Supplements, along with cost reductions and internalization of development, contribute to the improvements.
Second section heading
As for the outlook, the factors that led to actual results exceeding the full-year consolidated forecast for this term are expected to strengthen the earnings base for the next term and beyond. There is no currency impact described in the text. Segment-level profit improvements contribute to the overall profit rise, and strategies in healthcare-related and cosmetics/dietary supplement areas are bearing fruit.
Total Medical Research Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
